Jyrki Mattila Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jyrki Mattila.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jyrki Mattila. Jyrki Mattila is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Executive Vice President in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Business Officer in Lipocine Inc. ($LPCN) and Executive VP, Business Dev. in Recro Pharma, Inc. ($REPH).
Latest Insider Trading Transactions of Jyrki Mattila
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AUXL, BSTCE, LPCN, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 41.82 | 3,750 | 156,825 | 11,250 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 37.64 | 15,000 | 564,600 | 0 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Sell | S | 62.06 | 18,750 | 1,163,625 | 376 | 19.1 K to 376 (-98.03 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 41.82 | 3,750 | 156,825 | 19,126 | 15.4 K to 19.1 K (+24.39 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 37.64 | 15,000 | 564,600 | 15,376 | 376 to 15.4 K (+3,989.36 %) |
| Mar 19 2018 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | A | 41.82 | 15,000 | 627,300 | 15,000 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Mattila Jyrki | Executive VP, Busin ... | Option Exercise | A | 9.04 | 23,000 | 207,920 | 23,000 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Mattila Jyrki | Executive VP, Busin ... | Grant | A | 0.00 | 11,500 | 0 | 11,500 | 0 to 11.5 K |
| Aug 21 2017 | REPH | Recro Pharma, Inc. | Mattila Jyrki | Executive VP, Busin ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Aug 21 2017 | REPH | Recro Pharma, Inc. | Mattila Jyrki | Executive VP, Busin ... | Option Exercise | A | 6.98 | 75,000 | 523,500 | 75,000 | |
| Jan 30 2017 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Dec 08 2016 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 3.61 | 40,000 | 144,400 | 40,000 | |
| Jan 07 2016 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 12.92 | 40,000 | 516,800 | 40,000 | |
| Jun 15 2015 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 7.32 | 10,000 | 73,200 | 90,000 | |
| May 18 2015 | LPCN | Lipocine Inc. | Mattila Jyrki | Chief Business Offi ... | Option Exercise | A | 7.66 | 80,000 | 612,800 | 80,000 | |
| Apr 23 2015 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | A | 37.93 | 15,000 | 568,950 | 15,000 | |
| Jun 07 2005 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 5.36 | 105,000 | 562,800 | 105,000 | |
| Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 7.50 | 51,840 | 388,800 | 51,840 | |
| Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Grant | A | 0.00 | 11,520 | 0 | 11,520 | 0 to 11.5 K |
Page: 1